<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03923920</url>
  </required_header>
  <id_info>
    <org_study_id>18-1512</org_study_id>
    <nct_id>NCT03923920</nct_id>
  </id_info>
  <brief_title>Screening for Systemic Amyloidosis Via the Ligamentum Flavum</brief_title>
  <acronym>ALF</acronym>
  <official_title>Screening for Systemic Amyloidosis Via the Ligamentum Flavum</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will prospectively evaluate for the presence of amyloid deposits in
      ligamentum flavum (yellow ligament) tissue samples obtained from patients undergoing spinal
      stenosis surgery. Patients who have tissue that stains positive for amyloid will be referred
      to an amyloidosis specialist.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Similar to carpal tunnel syndrome, spinal stenosis is associated with systemic amyloidosis
      and presents earlier than cardiac amyloidosis symptoms - 21-45% of ATTR patients and case
      reports in AL patients. The investigators' recent study found that 10% of older patients
      undergoing carpal tunnel release surgery were positive for amyloidosis, with 20% of that
      group presenting with cardiac involvement. 70% of the amyloid-positive group had a history of
      spinal stenosis and 40% required surgical intervention. Surgical intervention for spinal
      stenosis could provide an opportunity to screen for amyloidosis through yellow ligament
      (ligamentum flavum) biopsy.

      This study will look at the prevalence of amyloidosis in patients undergoing surgical
      intervention for non-congenital spinal stenosis and spondyloarthropathy. The investigators
      hypothesize that 10% of such patients will be positive for amyloidosis.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2019</start_date>
  <completion_date type="Anticipated">October 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of amyloidosis in older patients undergoing spinal stenosis surgery</measure>
    <time_frame>Baseline to 30 days</time_frame>
    <description>Incidence of amyloid deposits in removed ligamentum flavum tissue of older patients undergoing spinal stenosis surgery</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Amyloid</condition>
  <condition>Amyloidosis</condition>
  <condition>Spinal Stenosis</condition>
  <condition>Transthyretin Amyloidosis</condition>
  <condition>Primary Amyloidosis of Light Chain Type</condition>
  <arm_group>
    <arm_group_label>Spinal Stenosis Biopsy</arm_group_label>
    <description>Biopsy of ligamentum flavum tissue during spinal stenosis surgery sent to pathology for amyloid-specific analysis</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Biopsy</intervention_name>
    <description>During clinically-scheduled spinal stenosis surgery, ligamentum flavum tissue (which may contain surrounding tissue and subcutaneous fat) that is removed during the procedure will be sent to pathology to be analyzed with amyloid-specific staining.</description>
    <arm_group_label>Spinal Stenosis Biopsy</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Ligamentum flavum tissue (may contain surrounding tissue and subcutaneous fat)
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing spinal stenosis surgery
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥50 years

          -  Undergoing surgical intervention for non-congenital spinal stenosis and/or
             spondyloarthropathy

          -  Able to consent

        Exclusion Criteria:

          -  History of congenital spinal stenosis or congenital spondyloarthropathy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Mazen A Hanna, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mazen A Hanna, MD</last_name>
    <phone>2164443490</phone>
    <email>Hannam@ccf.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Joseph P Donnelly, MD</last_name>
    <phone>3028932315</phone>
    <email>donnelj@ccf.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mazen Hanna, M. D.</last_name>
      <phone>216-444-3490</phone>
      <email>hannam@ccf.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Sperry BW, Reyes BA, Ikram A, Donnelly JP, Phelan D, Jaber WA, Shapiro D, Evans PJ, Maschke S, Kilpatrick SE, Tan CD, Rodriguez ER, Monteiro C, Tang WHW, Kelly JW, Seitz WH Jr, Hanna M. Tenosynovial and Cardiac Amyloidosis in Patients Undergoing Carpal Tunnel Release. J Am Coll Cardiol. 2018 Oct 23;72(17):2040-2050. doi: 10.1016/j.jacc.2018.07.092.</citation>
    <PMID>30336828</PMID>
  </reference>
  <reference>
    <citation>Yanagisawa A, Ueda M, Sueyoshi T, Okada T, Fujimoto T, Ogi Y, Kitagawa K, Tasaki M, Misumi Y, Oshima T, Jono H, Obayashi K, Hirakawa K, Uchida H, Westermark P, Ando Y, Mizuta H. Amyloid deposits derived from transthyretin in the ligamentum flavum as related to lumbar spinal canal stenosis. Mod Pathol. 2015 Feb;28(2):201-7. doi: 10.1038/modpathol.2014.102. Epub 2014 Sep 5.</citation>
    <PMID>25189643</PMID>
  </reference>
  <reference>
    <citation>Westermark P, Westermark GT, Suhr OB, Berg S. Transthyretin-derived amyloidosis: probably a common cause of lumbar spinal stenosis. Ups J Med Sci. 2014 Aug;119(3):223-8. doi: 10.3109/03009734.2014.895786. Epub 2014 Mar 12.</citation>
    <PMID>24620715</PMID>
  </reference>
  <reference>
    <citation>Sueyoshi T, Ueda M, Jono H, Irie H, Sei A, Ide J, Ando Y, Mizuta H. Wild-type transthyretin-derived amyloidosis in various ligaments and tendons. Hum Pathol. 2011 Sep;42(9):1259-64. doi: 10.1016/j.humpath.2010.11.017. Epub 2011 Feb 21.</citation>
    <PMID>21334722</PMID>
  </reference>
  <reference>
    <citation>Sekijima Y, Yazaki M, Ueda M, Koike H, Yamada M, Ando Y. First nationwide survey on systemic wild-type ATTR amyloidosis in Japan. Amyloid. 2018 Mar;25(1):8-10. doi: 10.1080/13506129.2017.1409706. Epub 2017 Nov 28.</citation>
    <PMID>29182024</PMID>
  </reference>
  <reference>
    <citation>M'bappé P, Grateau G. Osteo-articular manifestations of amyloidosis. Best Pract Res Clin Rheumatol. 2012 Aug;26(4):459-75. doi: 10.1016/j.berh.2012.07.003. Review.</citation>
    <PMID>23040361</PMID>
  </reference>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 18, 2019</study_first_submitted>
  <study_first_submitted_qc>April 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 23, 2019</study_first_posted>
  <last_update_submitted>April 29, 2020</last_update_submitted>
  <last_update_submitted_qc>April 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Cleveland Clinic</investigator_affiliation>
    <investigator_full_name>Mazen Hanna MD</investigator_full_name>
    <investigator_title>Principle Investigator</investigator_title>
  </responsible_party>
  <keyword>Biopsy</keyword>
  <keyword>Surgery</keyword>
  <keyword>Screening</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Immunoglobulin Light-chain Amyloidosis</mesh_term>
    <mesh_term>Spinal Stenosis</mesh_term>
    <mesh_term>Amyloidosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

